DE LUCA, GIAMPIERO,YTHIER, ARNAUD,MUNAFO, ALAIN,LOPEZ-BRESNAHAN, MARIA
申请号：
CA2588966
公开号：
CA2588966C
申请日:
2005.12.20
申请国别(地区):
CA
年份:
2020
代理人:
摘要：
The present invention is related to the use of Cladribine for the preparationof a pharmaceutical formulation for the treatment of multiple sclerosis,especially relapsing-remitting multiple sclerosis or early secondaryprogressive multiple sclerosis, wherein the preparation is to be the orallyadministered and wherein re-treatments are possible.
